Clinical Trial Update: Endothelin-1 and Cardiac Allograft Vasculopathy (CAV) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Endothelin-1 for Cardiac Allograft Vasculopathy has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: University of California, Los Angeles | Conditions: Cardiac Allograft Vasculopathy | Phase 4 | Status: COMPLETED | Results posted: 2024-03-12